Bankert v. Commissioner of the Social Security Administration

CourtDistrict Court, N.D. Ohio
DecidedSeptember 27, 2019
Docket5:18-cv-02016
StatusUnknown

This text of Bankert v. Commissioner of the Social Security Administration (Bankert v. Commissioner of the Social Security Administration) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bankert v. Commissioner of the Social Security Administration, (N.D. Ohio 2019).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

LEANNE BANKERT, ) CASE NO. 5:18-cv-2016 ) Plaintiff, ) ) v. ) MAGISTRATE JUDGE DAVID A. RUIZ ) ANDREW SAUL, ) Comm’r of Soc. Sec., ) MEMORANDUM OPINION AND ORDER ) Defendant. )

Plaintiff, Leanne Bankert (hereinafter “Plaintiff”), challenges the final decision of Defendant Andrew Saul, Commissioner of Social Security (hereinafter “Commissioner”), denying her applications for a Period of Disability (“POD”), Disability Insurance Benefits (“DIB”), and Supplemental Security Income (“SSI”) under Titles II and XVI of the Social Security Act, 42 U.S.C. §§ 416(i), 423, 1381 et seq. (“Act”). This court has jurisdiction pursuant to 42 U.S.C. § 405(g). This case is before the undersigned United States Magistrate Judge pursuant to consent of the parties. (R. 13 & 14). For the reasons set forth below, the Commissioner’s final decision is AFFIRMED. I. Procedural History On January 12, 2016, Plaintiff filed her applications for POD and DIB alleging a disability onset date of May 11, 2015. (Transcript (“Tr.”) 188-194). On September 2, 2016, Plaintiff filed an application for SSI alleging her disability began on August 23, 2016. (Tr. 195-201). The ap plications were denied initially and upon reconsideration, and Plaintiff requested a hearing before an Administrative Law Judge (“ALJ”). (Tr. 108-126). Plaintiff participated in the hearing on November 21, 2017, was represented by counsel, and testified. (Tr. 38-75). A vocational expert (“VE”) also participated and testified. Id. On January 18, 2018, the ALJ found Plaintiff not disabled. (Tr. 18-32). On July 10, 2018, the Appeals Council denied Plaintiff’s request to review the ALJ’s decision, and the ALJ’s decision became the Commissioner’s final decision. (Tr. 1-7). On September 4, 2018, Plaintiff filed a complaint challenging the Commissioner’s final decision. (R. 1). The parties have completed briefing in this case. (R. 11 & 12). Plaintiff asserts the following assignments of error: (1) the ALJ erred in evaluating the opinion of Plaintiff’s treating neurologist; and, (2) the ALJ erred in evaluating Plaintiff’s credibility. (R. 11). II. Evidence A. Relevant Medical Evidence1 1. Treatment Records

Prior to the alleged onset date, on October 31, 2014, Plaintiff returned to the Neurology Clinic and was seen by Jose M. Casanova, M.D., Ph.D. (Tr. 522). She carried a diagnosis of “chronic migraine without aura, intractable, no status.” Id. Plaintiff reported her headaches were well controlled and denied any side effects from her medications. Id. Plaintiff received Botox injections into the skull and neck muscles. Id. On May 15, 2015, after the alleged onset date, Dr. Casanova administered Botox injections.

1 The recitation of the evidence is not intended to be exhaustive. It includes only those portions of the record cited by the parties in their briefs and also deemed relevant by the court to the assignments of error raised. (T r. 518). Plaintiff again reported doing well, but her headaches remained unchanged. Id. On July 12, 2015, Plaintiff presented to the ER with a migraine beginning at 10 a.m. that day. (Tr. 360). She was discharged the same day. (Tr. 370). On September 2, 2015, Plaintiff presented for Botox injections and reported that her headaches remained unchanged. (Tr. 514). She denied any visits to the ER. Id. On September 21, 2015, Plaintiff was referred by Dr. Casanova to Robert Felden, D.O., who noted Plaintiff had a “migraine headache for several months now,” for a lidocaine infusion. (Tr. 537). Dr. Felden noted that Plaintiff had received such infusions in the past and had “done well” with diminution of her overall headache pain. Id. On November 25, 2015, Dr. Casanova administered Botox injections. (Tr. 512). Plaintiff again reported doing well. Id. She reported significant stress since working for AultCare, but denied missing any days of work or visits to the ER. Id. On January 11, 2016, Plaintiff was seen by Dr. Hiestand for follow-up of her diabetes mellitus type II, hypertension, mild hyperlipidemia, and chronic headaches. (Tr. 687). She was

noted as having a “little bit” of paresthesia in her fingertips and toes for the past couple years. Id. She was doing “fairly well” with her headaches and periodically taking Lorazepam. Id. Dr. Hiestand was uncertain whether the paresthesia was attributable to Topamax or diabetes. Id. On February 24, 2016, Dr. Casanova administered Botox injections. (Tr. 699, 721). Plaintiff reported that “her headaches appear to be well controlled,” and she denied any side effects from medications. Id. She denied any visits to the ER. Id. On April 30, 2016, Plaintiff presented to the ER with a headache that she stated persisted for about a week and a half. (Tr. 711). Stephen Miller, D.O. examined Plaintiff; the results were unremarkable. Id. She reported last being in the ER in July of 2015 with similar symptoms. (Tr. 71 2). She was given Reglan and Toradol. (Tr. 714). On June 9, 2016, Plaintiff was seen in pain management reporting an acute migraine of three months duration. (Tr. 724). Dr. Felden administered an intravenous infusion of Propofol and Lidocaine. (Tr. 724-725). On August 26, 2016, Dr. Casanova again administered Botox injections. (Tr. 742). Plaintiff was “doing well,” her headaches appeared “well controlled,” and she denied any side effects from medications. Id. On November 23, 2016, Dr. Casanova again administered Botox injections. (Tr. 750). Plaintiff reported that her headaches were “well controlled,” that her headaches improved after she stopped working at Aultman, and she denied any side effects from medications. Id. On February 15, 2017, Dr. Casanova again administered Botox injections. (Tr. 748). Plaintiff again reported she was “doing well.” Id. She denied any new problems and reported “at least 50% improvement with [Botox] injections.” Id. On August 2, 2017, Dr. Casanova again administered Botox injections. (Tr. 857). Plaintiff

again reported she was “doing well.” Id. She denied any new ER visits, reported “at least 50% improvement with [Botox] injections,” and reported only two headaches since her last injections. Id. Eleven days later, on August 13, 2017, Plaintiff presented to the ER reporting a migraine headache of two to three weeks in duration. (Tr. 849). Plaintiff described her current pain as 6/10 and that her medications were not helping. Id. Plaintiff was given intravenous fluids and a migraine cocktail. (Tr. 851). Later the same day, she reported feeling much improved with her headache at 1-2/10 in severity. Id. On October 25, 2017, Dr. Casanova administered Botox injections. (Tr. 856). Plaintiff ag ain reported she was “doing well.” Id. She denied any new problems or any ER visits. Id. On November 3, 2017, Plaintiff reported to Dr. Casanova that neither her Norco nor her Dilaudid medications work very well. (Tr. 858). If she had to choose, she preferred Norco at increased doses. (Tr. 858). Dr. Casanova noted Plaintiff had been taking Norco for eleven years and believed it better to switch pain medications. (Tr. 858). Plaintiff was started on Oxymorphone. (Tr. 860). Three days later, on November 6, 2017, Plaintiff presented to the ER reporting a migraine headache that started ten days earlier. (Tr. 865). Plaintiff described her current pain as 9/10. Id. Plaintiff was given intravenous fluids and medications, but reported improvement only to 7/10 pain. (Tr. 868). She stated that “she typically needs Dilaudid to feel improved.” Id. She was given one dose of Dilaudid prior to discharge and told to follow up with her primary care physician and neurologist. (Tr. 868). 2.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kirk v. Secretary of Health and Human Services
667 F.2d 524 (Sixth Circuit, 1981)
Ruby E. Heston v. Commissioner of Social Security
245 F.3d 528 (Sixth Circuit, 2001)
Jimmie L. Howard v. Commissioner of Social Security
276 F.3d 235 (Sixth Circuit, 2002)
Angela M. Jones v. Commissioner of Social Security
336 F.3d 469 (Sixth Circuit, 2003)
Robert M. Wilson v. Commissioner of Social Security
378 F.3d 541 (Sixth Circuit, 2004)
Debra Rogers v. Commissioner of Social Security
486 F.3d 234 (Sixth Circuit, 2007)
Ealy v. Commissioner of Social Security
594 F.3d 504 (Sixth Circuit, 2010)
Bowie v. Commissioner of Social SEC.
539 F.3d 395 (Sixth Circuit, 2008)
White v. Commissioner of Social Security
572 F.3d 272 (Sixth Circuit, 2009)
Cross v. Commissioner of Social Security
373 F. Supp. 2d 724 (N.D. Ohio, 2005)
Masch v. Barnhart
406 F. Supp. 2d 1038 (E.D. Wisconsin, 2005)
Doris Poe v. Commissioner of Social Security
342 F. App'x 149 (Sixth Circuit, 2009)
Frank Dooley, Jr. v. Comm'r of Social Security
656 F. App'x 113 (Sixth Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
Bankert v. Commissioner of the Social Security Administration, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bankert-v-commissioner-of-the-social-security-administration-ohnd-2019.